Deciphering the Fasciola hepatica Glycocode and Its Involvement in Host-Parasite Interactions
Jaclyn Swan1, Timothy C Cameron1, Terry W Spithill1
1Department of Ecological Plant and Animal Science, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC 3086, Australia.
Biomolecules
|September 27, 2025
Summary
Fasciolosis, caused by the liver fluke *Fasciola hepatica*, requires new treatments due to drug resistance. Understanding its surface glycans is key to developing novel vaccines and therapies against this zoonotic parasite.
Area of Science:
- Parasitology
- Glycobiology
- Immunology
Background:
- Fasciolosis, a zoonotic disease caused by *Fasciola hepatica* (liver fluke), threatens human and livestock health.
- Drug resistance in *F. hepatica* necessitates novel therapeutic strategies.
- The parasite's tegument glycocalyx is a critical host-parasite interface.
Purpose of the Study:
- To review current knowledge on *F. hepatica* glycosylation.
- To explore identified glycan motifs and their interactions with host lectins.
- To highlight the potential of glycans as targets for new treatments and vaccines.
Main Methods:
- Literature review consolidating existing research.
- Analysis of glycan motifs identified via lectin probing and mass spectrometry.
- Examination of glycoconjugate interactions with host immune lectins.
Main Results:
- Glycans on the *F. hepatica* surface are crucial for host-parasite interactions.
- Specific glycan motifs have been identified.
- Interactions between parasite glycans and host lectins are significant.
Conclusions:
- Understanding *F. hepatica* glycosylation is vital for developing new anti-parasitic strategies.
- Glycans offer promising targets for novel vaccines and drug therapies.
- Future vaccine design can be enhanced by integrating glycosylation insights.
